Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of Intraoperative Frozen Section Analysis with Final Histopathology Results for Sentinel Lymph Node Biopsy: Z0011 Criteria Eligible Versus Ineligible Breast Cancer Patients.
Reinhardt F, Fiedler A, Borgmeier F, Reinecke P, Esposito I, Mattes-György K, Dabir M, Friebe V, Krawczyk N, Kaleta T, Hoffmann J, Ruckhäberle E, Fehm T, Roth KS, Mohrmann S. Reinhardt F, et al. Among authors: friebe v. Geburtshilfe Frauenheilkd. 2022 Jun 3;82(6):610-618. doi: 10.1055/a-1749-5226. eCollection 2022 Jun. Geburtshilfe Frauenheilkd. 2022. PMID: 35903717 Free PMC article.
Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography.
Dietzel F, Kolberg L, Vesper AS, Hoffmann J, Nestle-Krämling C, Zwiefel K, Friebe V, Sawicki LM, Bruckmann NM, Jannusch K, Morawitz J, Antoch G, Fehm TN, Kirchner J, Mohrmann S. Dietzel F, et al. Among authors: friebe v. Cancers (Basel). 2023 Jan 29;15(3):829. doi: 10.3390/cancers15030829. Cancers (Basel). 2023. PMID: 36765786 Free PMC article.
Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.
Mohrmann S, Kolberg L, Jäger B, Hoffmann J, Nestle-Krämling C, Zwiefel K, Friebe V, Sawicki LM, Bruckmann NM, Jannusch K, Morawitz J, Antoch G, Fehm TN, Kirchner J, Dietzel F. Mohrmann S, et al. Among authors: friebe v. Eur J Surg Oncol. 2023 Nov;49(11):107031. doi: 10.1016/j.ejso.2023.107031. Epub 2023 Aug 24. Eur J Surg Oncol. 2023. PMID: 37683424